Occam Places Geoff McDonough as CEO of Generation Bio
Generation Bio, a Casdin/Atlas investment, is a now public gene therapy company focused on providing treatment for patients living with rare, genetic diseases.
In late 2019, Occam was hired by Atlas Venture to build a complete C-level leadership team around the company’s platform. One of our placements was Geoff McDonough, MD as CEO along with a CFO who later took the company public, raising $125M in the process. Previously, McDonough served as the CEO of Swedish biopharmaceutical, Sobi, following a lengthy tenure at Genzyme.
Recent Placements
Occam Global is a trusted executive search, consulting, and investment partner for leaders and investors shaping the future of life sciences, deep tech, and venture capital. Since 2012, we’ve helped build high-performing teams and advised visionary companies from stealth to public markets. Our success stems from exceptional access to rare talent, deep sector expertise, and a commitment to results guided by elevated ethics and enlightened aggression.